Table 2.
Brachial artery flow-mediated dilation before and after exercise training and time control
PHRT (N = 15)
|
PHET (N = 13)
|
PHTC (N = 15)
|
NMTC (N = 15)
|
|||||
---|---|---|---|---|---|---|---|---|
Before | After | Before | After | Before | After | Before | After | |
Baseline diameter (mm) | 4.18 ± 0.06 | 4.29 ± 0.06 | 3.91 ± 0.06 | 4.01 ± 0.07 | 3.99 ± 0.03 | 4.05 ± 0.04 | 4.24 ± 0.05 | 4.40 ± 0.06 |
Absolute dilation (mm) | 0.26 ± 0.12* | 0.34 ± 0.14† | 0.22 ± 0.10* | 0.34 ± 0.19† | 0.24 ± 0.11* | 0.18 ± 0.09* | 0.35 ± 0.08 | 0.36 ± 0.09 |
FMD (%) | 6.17 ± 3.07* | 8.30 ± 4.10† | 5.92 ± 3.80* | 9.64 ± 5.13† | 6.20 ± 3.69* | 5.85 ± 3.96* | 8.23 ± 1.95 | 8.30 ± 1.57 |
Normalized FMD (s−1) | 0.21 ± 0.12* | 0.25 ± 0.12† | 0.16 ± 0.07* | 0.28 ± 0.13† | 0.19 ± 0.10* | 0.19 ± 0.08* | 0.29 ± 0.11 | 0.29 ± 0.07 |
Values are mean ± SD. FMD, flow-mediated dilation; NMTC, normotensive matched time-control; PHET, prehypertensive endurance training; PHRT, prehypertensive resistance training; PHTC, prehyppertensive time-control. Significance values are reported from between group and between timepoint repeated measures ANOVA and Tukey’s post hoc analysis
P< 0.05 baseline versus normotensive control values
P< 0.05 versus pretreatment values